ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
ICU Medical (Nasdaq: ICUI) announced that company management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, January 12–15, 2026.
The live presentation is scheduled for Wednesday, January 14, 2026 at 1:30 p.m. PT (4:30 p.m. ET), with management also holding one-on-one meetings that day. The presentation will be webcast live and available for replay on the company investor website under the Events or Investor Calendar section.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, ICUI declined 1.36%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers in Medical Instruments & Supplies showed mixed moves: WRBY -3.84%, TFX -0.58%, while NVST, XRAY, and MMSI were modestly positive. No consistent sector-wide direction relative to ICUI’s -1.77% move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 20 | Conference participation | Neutral | +1.3% | Announcement of Piper Sandler healthcare conference fireside chat and meetings. |
| Nov 06 | Earnings & guidance | Positive | +1.8% | Q3 2025 results with improved margins and raised FY2025 guidance. |
| Oct 23 | Earnings call timing | Neutral | -0.6% | Scheduling details for Q3 2025 earnings release and conference call. |
| Aug 21 | Investor conferences | Neutral | -1.3% | Planned participation in Wells Fargo and Morgan Stanley healthcare conferences. |
| Aug 07 | Earnings & guidance | Positive | -13.1% | Q2 2025 results with improved profitability and updated FY2025 guidance. |
Recent ICUI news, especially earnings and conference participation, has more often seen price moves align with the nature of the news, with one notable divergence on an earnings/guidance update.
Over the last few months, ICU Medical has combined investor outreach with improving fundamentals. Q2 and Q3 2025 earnings showed stronger profitability and updated FY2025 guidance, while filings detailed debt reduction and a strategic divestiture. Multiple conference and fireside chat appearances in August–December 2025 emphasized ongoing investor engagement. Today’s J.P. Morgan Healthcare Conference presentation notice continues this pattern of regular communication following operational and financial updates.
Market Pulse Summary
This announcement highlights ICU Medical’s upcoming presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, with management also holding one-on-one meetings and providing a live and replayable webcast. It continues a series of investor-focused events following Q2 and Q3 2025 results and guidance updates. Investors may watch for any incremental commentary on strategy, margins, and capital allocation during the conference appearance.
AI-generated analysis. Not financial advice.
SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 12-15, 2026. ICU Medical’s presentation will be on Wednesday, January 14, 2026 at 1:30 p.m. PT (4:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 14, 2026.
The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT:
ICU Medical
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.